High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration.

The present report describes the non-haematological toxicity and the influence of growth factor administration on haematological toxicity and haematopoietic recovery observed after high-dose carboplatin (1200 mg m(-2)), etoposide (900 mg m(-2)) and melphalan (100 mg m(-2)) (CEM) followed by peripher...

Descripción completa

Detalles Bibliográficos
Autores principales: Benedetti Panici, P., Pierelli, L., Scambia, G., Foddai, M. L., Salerno, M. G., Menichella, G., Vittori, M., Maneschi, F., Caracussi, U., Serafini, R., Leone, G., Mancuso, S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222783/
https://www.ncbi.nlm.nih.gov/pubmed/9099971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222783/
https://www.ncbi.nlm.nih.gov/pubmed/9099971

Ejemplares similares